No idea what's going on. Volume's come out of nowhere, and we have a breakout. Maybe the sales team are really starting to kick in? Low overheads - cost increases are primarily based upon commission payments. DYOR.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025